Association between DRD2/DRD4 interaction and conduct disorder: A potential developmental pathway to alcohol dependence

Authors

  • Nina R. Mota,

    Corresponding author
    1. King's College London, Institute of Psychiatry, MRC Social Genetic and Developmental Psychiatry Centre, London, United Kingdom, UK
    • Depatment of Genetics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
    Search for more papers by this author
  • Claiton H. D. Bau,

    1. Depatment of Genetics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
    Search for more papers by this author
  • Tobias Banaschewski,

    1. Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
    Search for more papers by this author
  • Jan K. Buitelaar,

    1. Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands
    Search for more papers by this author
  • Richard P. Ebstein,

    1. Psychology Department, National University of Singapore, Singapore, Singapore
    Search for more papers by this author
  • Barbara Franke,

    1. Department of Psychiatry, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands
    2. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands
    Search for more papers by this author
  • Michael Gill,

    1. Department of Psychiatry, Trinity Centre for Health Sciences, St. James's Hospital, Dublin, Ireland
    Search for more papers by this author
  • Jonna Kuntsi,

    1. King's College London, Institute of Psychiatry, MRC Social Genetic and Developmental Psychiatry Centre, London, United Kingdom, UK
    Search for more papers by this author
  • Iris Manor,

    1. ADHD Unit, Geha Mental Health Centre, Petach-Tiqva, Israel
    Search for more papers by this author
  • Ana Miranda,

    1. Department of Developmental and Educational Psychology, University of Valencia, Valencia, Spain
    Search for more papers by this author
  • Fernando Mulas,

    1. Neuropediatrics Unit, La Fé University Hospital, Valencia, Spain
    Search for more papers by this author
  • Robert D. Oades,

    1. University Clinic for Child and Adolescent Psychiatry, Essen, Germany
    Search for more papers by this author
  • Herbert Roeyers,

    1. Department of Experimental Clinical and Health Psychology, Ghent University, Ghent, Belgium
    Search for more papers by this author
  • Aribert Rothenberger,

    1. Child and Adolescent Psychiatry, University of Göttingen, Göttingen, Germany
    Search for more papers by this author
  • Joseph A. Sergeant,

    1. Department of Clinical Neuropsychology, Vrije Universiteit, Amsterdam, The Netherlands
    Search for more papers by this author
  • Edmund J. Sonuga-Barke,

    1. Department of Experimental Clinical and Health Psychology, Ghent University, Ghent, Belgium
    2. Institute for Disorder on Impulse and Attention, School of Psychology, University of Southampton, Southampton, United Kingdom, UK
    Search for more papers by this author
  • Hans-Christoph Steinhausen,

    1. Department of Child and Adolescent Psychiatry, University of Zurich, Zurich, Switzerland
    2. Clinical Psychology and Epidemiology, Institute of Psychology, University of Basel, Basel, Switzerland
    3. Research Unit for Child and Adolescent Psychiatry, Psychiatric Hospital, Aalborg University Hospital, Aalborg, Denmark
    Search for more papers by this author
  • Stephen V. Faraone,

    1. Department of Neuroscience, SUNY Upstate Medical University, Syracuse, New York
    2. Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York
    Search for more papers by this author
  • Philip Asherson

    1. King's College London, Institute of Psychiatry, MRC Social Genetic and Developmental Psychiatry Centre, London, United Kingdom, UK
    Search for more papers by this author

  • Conflicts of interest: Consultancy fees were received by PA, TB, and AR from Shire, Lilly, Novartis, and Medice; and TB from Bristol Myers-Squibb, Develco Pharma and Vifor Pharma; and PA and TB from Janssen. Speaker/travel fees were paid to PA and TB from Shire, Lilly, Novartis, Janssen, and Medice; and AR from shire. PA held educational or research grants from Janssen, Shire, Vifor and QBTech; and AR from Shire. The present work is unrelated to the above grants and relationships. No other conflicts of interest are noted.

Correspondence to:

Nina Roth Mota, M.Sc., Department of Genetics, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.

E-mail address: ninarothmota@gmail.com

Correspondence to:

Prof. Philip Asherson, MRC Social Genetic and Developmental Psychiatry, Institute of Psychiatry, Kings College London, London SE 58AF, UK.

E-mail address: philip.asherson@kcl.ac.uk

Abstract

© 2013 Wiley Periodicals, Inc.

Ancillary